470 related articles for article (PubMed ID: 22309388)
21. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.
Giannarelli C; Cimmino G; Connolly TM; Ibanez B; Ruiz JM; Alique M; Zafar MU; Fuster V; Feuerstein G; Badimon JJ
Eur Heart J; 2012 Jan; 33(2):264-73. PubMed ID: 21606082
[TBL] [Abstract][Full Text] [Related]
22. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
[TBL] [Abstract][Full Text] [Related]
23. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits.
Lu XT; Liu YF; Zhang L; Yang RX; Liu XQ; Yan FF; Wang YB; Bai WW; Zhao YX; Jiang F
Psychosom Med; 2012; 74(6):604-11. PubMed ID: 22753638
[TBL] [Abstract][Full Text] [Related]
24. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
25. In vivo MR imaging of plaque disruption and thrombus formation in an atherosclerotic rabbit model.
Ma X; Zhao Q; Zhao L; Shang J; Feng T; Zeng C; Zhang Z
Int J Cardiovasc Imaging; 2012 Mar; 28(3):577-86. PubMed ID: 21461662
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
[TBL] [Abstract][Full Text] [Related]
27. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
[TBL] [Abstract][Full Text] [Related]
28. [Induction of atherosclerotic plaque instability in rabbits after transfection of human wild-type p53 gene].
Chen WQ; Zhang Y; Zhang M; Ji XP; Lin C; Zhu YF; Zhang W; Wang R; Liu Y; Yao GH
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):43-7. PubMed ID: 14990158
[TBL] [Abstract][Full Text] [Related]
29. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques.
Lin HL; Xu XS; Lu HX; Zhang L; Li CJ; Tang MX; Sun HW; Liu Y; Zhang Y
J Mol Cell Cardiol; 2007 Sep; 43(3):272-80. PubMed ID: 17628589
[TBL] [Abstract][Full Text] [Related]
30. Appropriate doses of granulocyte-colony stimulating factor reduced atherosclerotic plaque formation and increased plaque stability in cholesterol-fed rabbits.
Matsumoto T; Watanabe H; Ueno T; Tsunemi A; Hatano B; Kusumi Y; Mitsumata M; Fukuda N; Matsumoto K; Saito S; Mugishima H
J Atheroscler Thromb; 2010 Feb; 17(1):84-96. PubMed ID: 20081322
[TBL] [Abstract][Full Text] [Related]
31. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of rupture of atherosclerotic plaque by Candesartan in rabbit model].
Zhou XF; Yin HC; Zhu WL; Shen L; Yu T; Li SA; Meng ZM; Wu AS; Qian HD
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):106-11. PubMed ID: 20388376
[TBL] [Abstract][Full Text] [Related]
33. EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit.
Tavridou A; Kaklamanis L; Papalois A; Kourounakis AP; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG
J Pharmacol Exp Ther; 2007 Dec; 323(3):794-804. PubMed ID: 17804677
[TBL] [Abstract][Full Text] [Related]
34. [Study on the correlation of the levels of serum IFN-γ and RANTES and rabbit vulnerable atherosclerotic plaque].
Wen HY; Peng YD; Cheng LX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):846-8. PubMed ID: 21806879
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties.
Wang SS; Hu SW; Zhang QH; Xia AX; Jiang ZX; Chen XM
PLoS One; 2015; 10(8):e0136026. PubMed ID: 26288013
[TBL] [Abstract][Full Text] [Related]
36. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
Abela GS
J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
[TBL] [Abstract][Full Text] [Related]
37. Doxycycline stabilizes vulnerable plaque via inhibiting matrix metalloproteinases and attenuating inflammation in rabbits.
Dong M; Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Li L; Yao GH; Zhang PF; Zhang C; Zhang L; Zhang Y
PLoS One; 2012; 7(6):e39695. PubMed ID: 22737253
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
Zhao XC; Zhao QM; Ma XH; Zeng CH; Feng TT; Zhao X; Zhang ZQ; Zhang MD; Zhuang XC
Chin Med J (Engl); 2013; 126(11):2163-7. PubMed ID: 23769577
[TBL] [Abstract][Full Text] [Related]
39. Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits.
Hemn HO; Noordin MM; Rahman HS; Hazilawati H; Zuki A; Chartrand MS
Drug Des Devel Ther; 2015; 9():4173-208. PubMed ID: 26347047
[TBL] [Abstract][Full Text] [Related]
40. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
Gomes FLT; Maranhão RC; Tavares ER; Carvalho PO; Higuchi ML; Mattos FR; Pitta FG; Hatab SA; Kalil-Filho R; Serrano CV
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
